Can cannabis interfere with Mestinon (pyridostigmine) in patients with myasthenia gravis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Cannabis may potentially interfere with Mestinon (pyridostigmine) in patients with myasthenia gravis, and caution is advised. Patients with myasthenia gravis who are taking Mestinon should consult their neurologist before using cannabis in any form. The main concern is that cannabis contains compounds that might affect neuromuscular transmission and could theoretically worsen muscle weakness or interfere with the effectiveness of pyridostigmine. Mestinon works by inhibiting acetylcholinesterase, which increases acetylcholine levels at the neuromuscular junction to improve muscle strength. Cannabis, particularly THC, can affect the central nervous system and potentially impact neuromuscular function, as it inhibits the cytochrome P450 family of enzymes, specifically CYP3A4, UGT1A9, UGT2B7, CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP2C19, which may lead to altered drug metabolism pharmacokinetics 1.

Some key points to consider:

  • Cannabis can increase the risk of drug-drug interactions, particularly with medications that are metabolized by the cytochrome P450 family of enzymes 1.
  • Patients with myasthenia gravis may have impaired neuromuscular transmission, making them more sensitive to the effects of certain medications, including non-depolarizing neuromuscular blocking agents 1.
  • Smoking cannabis could exacerbate respiratory issues in myasthenia gravis patients who may already have compromised respiratory function.
  • Patients who choose to use cannabis should monitor for any changes in their myasthenic symptoms, particularly increased weakness, difficulty swallowing, or breathing problems, and report these immediately to their healthcare provider.
  • The medication regimen for Mestinon should never be adjusted without medical supervision, regardless of cannabis use.

From the Research

Interaction between Cannabis and Mestinon in Myasthenia Gravis

There are no direct studies on the interaction between cannabis and Mestinon (pyridostigmine) in patients with myasthenia gravis. However, we can look at the available information on Mestinon and its interactions with other substances.

Mestinon and Myasthenia Gravis

  • Mestinon (pyridostigmine) is a commonly used medication for the treatment of myasthenia gravis, an autoimmune disorder that affects the nervous system 2.
  • It works by inhibiting the breakdown of acetylcholine, a neurotransmitter that plays a key role in muscle contraction 2.
  • Pyridostigmine has been used for over 50 years and is generally considered safe, but it can cause side effects such as muscle cramps, diarrhea, and abdominal cramps 3.

Potential Interactions with Cannabis

  • There is limited research on the interaction between cannabis and Mestinon, but cannabis has been shown to have effects on the nervous system and muscle function 4.
  • Cannabis may potentially interact with Mestinon by enhancing its effects or increasing the risk of side effects, but more research is needed to confirm this 4.
  • A study on the perioperative management of myasthenia gravis patients recommends continuing pyridostigmine on the day of surgery, but it does not mention cannabis specifically 5.

Conclusion is not allowed, and the response should continue with more information

More Information on Mestinon

  • Mestinon is often used in combination with other medications, such as azathioprine and prednisolone, to treat myasthenia gravis 6.
  • The effectiveness and side effects of pyridostigmine have been studied in a cross-sectional study, which found that 61% of patients reported currently using pyridostigmine, and 91% of those patients reported side effects 3.
  • The study also found that the most frequently reported side effects were flatulence, urinary urgency, muscle cramps, blurred vision, and hyperhidrosis 3.

Note: There are no research papers to assist in answering the question about the interaction between cannabis and Mestinon in patients with myasthenia gravis. The information provided is based on the available studies on Mestinon and its use in treating myasthenia gravis, as well as the potential effects of cannabis on the nervous system and muscle function 4, 2, 6, 3, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.